William Blair Analysts Lift Earnings Estimates for MRSN
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) – Equities research analysts at William Blair lifted their Q2 2025 earnings per share estimates for shares of Mersana Therapeutics in a report issued on Thursday, May 15th. William Blair analyst A. Hsieh now forecasts that the company will post earnings of ($0.18) per share for the quarter, […]
